Biogen Inc.: Biogen Announces Two New Nominees for Election to Board of Directors
Company thanks Director Robert W. Pangia as he retires from the Board
CAMBRIDGE, Mass., April 09, 2021(Nasdaq: BIIB) today announced the nomination of Maria C. Freire, Ph.D. and William D. Jones to stand for election to the company s board of directors at its 2021 annual meeting of stockholders, scheduled for June 2, 2021. Additionally, Robert W. Pangia, who has served on the board since 1997 and is Chair of the Compensation and Management Development Committee, will retire from the company s board this year, effective at the annual meeting of stockholders.
Dr. Freire is President and Executive Director and member of the board of directors of the Foundation for the National Institutes of Health, a nonprofit organization committed to accelerating biomedical research and advancing breakthrough discoveries to fight critical diseases. Mr. Jones is the President and Chief Executive Officer and a director
GlaxoSmithKline PLC (NYSE:GSK), Royalty Pharma plc (NASDAQ:RPRX) - Royalty Pharma Buys Royalty Interest In Cabozantinib Products From GSK
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
MERCK KGAA DM 5 (MKGAF), (MKKGY) - Exelixis XL092 To Be Tested In Combination With Bavencio In Urothelial Carcinoma
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.